You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Merck
Medtronic
Harvard Business School
McKinsey
Dow
Colorcon

Last Updated: September 30, 2020

DrugPatentWatch Database Preview

Litigation Details for Universal Entertainment Corporation v. Aruze Gaming America, Inc. (D. Nev. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Universal Entertainment Corporation v. Aruze Gaming America, Inc. (D. Nev. 2018)

Docket   Start Trial Date Filed 2018-03-30
Court District Court, D. Nevada Date Terminated
Cause 35:271 Patent Infringement Assigned To Richard Franklin Boulware II
Jury Demand Both Referred To Nancy J. Kopp
Patents 10,011,643; 10,011,857; 10,016,365; 10,023,854; 10,023,892; 10,034,879; 10,040,857; 10,053,489; 10,064,948; 10,066,235; 10,071,953; 10,072,301; 10,087,260; 10,092,513; 10,092,706; 10,099,996; 10,100,330; 10,138,522; 10,195,237; 10,335,463; 10,335,489; 10,470,470; 10,519,252; 10,556,037; 10,585,088; 10,588,945; 10,588,950; 10,588,962; 6,007,507; 6,010,726; 6,016,879; 6,039,998; 6,051,235; 6,051,236; 6,100,444; 6,242,003; 6,472,006; 6,793,696; 6,793,949; 6,803,033; 6,804,365; 6,814,031; 6,881,726; 6,881,854; 6,900,173; 6,953,120; 7,022,356; 7,026,330; 7,037,513; 7,045,601; 7,045,643; 7,064,246; 7,078,236; 7,078,588; 7,238,856; 7,238,865; 7,249,802; 7,273,963; 7,365,241; 7,423,135; 7,494,682; 7,601,520; 7,655,038; 7,682,802; 7,696,236; 7,803,998; 7,851,643; 7,858,845; 7,998,225; 7,998,953; 8,008,338; 8,008,454; 8,025,900; 8,039,511; 8,039,682; 8,048,854; 8,057,892; 8,057,998; 8,058,317; 8,067,237; 8,119,173; 8,124,588; 8,237,003; 8,252,044; 8,273,950; 8,330,006; 8,338,365; 8,361,173; 8,392,124; 8,409,643; 8,410,088; 8,501,030; 8,501,225; 8,501,423; 8,507,007; 8,507,702; 8,556,864; 8,637,002; 8,637,096; 8,637,655; 8,715,963; 8,728,519; 8,728,546; 8,729,059; 8,729,127; 8,729,338; 8,735,392; 8,754,011; 8,754,096; 8,772,246; 8,802,099; 8,859,494; 8,865,854; 8,865,949; 8,865,953; 8,877,173; 8,895,033; 8,895,047; 8,895,070; 8,895,085; 8,895,546; 8,900,856; 8,962,000; 8,981,135; 9,011,949; 9,012,508; 9,050,262; 9,051,260; 9,078,726; 9,089,489; 9,095,643; 9,144,585; 9,201,068; 9,201,078; 9,237,945; 9,238,678; 9,238,682; 9,238,728; 9,242,011; 9,249,422; 9,409,850; 9,409,996; 9,410,059; 9,463,249; 9,511,031; 9,522,945; 9,556,138; 9,650,327; 9,650,444; 9,655,845; 9,655,880; 9,655,892; 9,670,066; 9,670,262; 9,670,500; 9,670,513; 9,678,075; 9,682,061; 9,682,124; 9,682,135; 9,725,444; 9,803,019; 9,845,338; 9,850,070; 9,850,472; 9,850,473; 9,856,438; 9,856,454; 9,862,772; 9,877,962; 9,879,067; 9,879,088; 9,895,423; 9,950,049; 9,963,507; 9,963,511; 9,981,021; 9,981,058; 9,981,087; RE46,276; RE46,284; RE46,290; RE46,363; RE46,365; RE46,375; RE46,604; RE46,617; RE46,856
Link to Docket External link to docket
Biologic Drugs cited in Universal Entertainment Corporation v. Aruze Gaming America, Inc.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Universal Entertainment Corporation v. Aruze Gaming America, Inc. (D. Nev. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-08 194 Order on Motion for Miscellaneous Relief 30 March 2018 2:18-cv-00585-RFB-NJK Patent Both District Court, D. Nevada…report] in Japan, not the U.S. patents at 15 issue” in this case. Id. at 9. In reply, Defendants submit … 2020 PACER Document Case 2:18-cv-00585-RFB-NJK Document 194 Filed 05/08/20 Page 1 of 8 … Case No.: 2:18-cv-00585-RFB-NJK 7 Plaintiff, … 1 Case 2:18-cv-00585-RFB-NJK Document 194 Filed 05/08/20 Page 2 of 8 External link to document
2018-07-03 20 Response in 2012 (see Compl. Exhs. C, D), and patents RE46,472 and RE46,473 issued nearly a year ago, in July …Exhibit '472 Patent, # 3 Exhibit '473 Patent, # 4 Exhibit '013 Patent, # 5 Exhibit '047 Patent, # 6 Exhibit…extend until the patents expire. The ‘047 patent expires in 2024; the ‘472 and ‘473 patents expire in …state law to police patent-holder’s enforcement of patent rights or conduct by patent applicants 17 …domain.’”); Neonatal Product Group, Inc. v. Shields, 276 F.Supp.3d 1120, 1151 (D. Kansas 2017) (Counterclaim External link to document
2020-05-30 201 Order on Motion to Dismiss AND Order AND Order on Motion to Dismiss . Claim Ten: Breach of Patent License Agreement 10 Claim ten is a breach of patent license…the “‘013 Patent”) was issued. 10 On December 10, 1998, Universal filed U.S. Patent Application…09/208,696, and on 11 August 21, 2012, U.S. Patent No. 8,246,047 (the “‘047 Patent”) was issued. 12 …filed U.S. Patent Application No. 14/961,361, and on July 13 11, 2017, U.S. Reissue Patent No. 46,472…962,087, and on July 15 11, 2017, U.S. Reissue Patent No. 46,473 (the “‘473 Patent”) was issued. (The Court External link to document
2020-06-01 203 Order Beckman Indus., Inc. v. Int’l Ins. Co., 966 F.2d 470, 476 (9th Cir. 1992). 14 If the sole ground…30 March 2018 2:18-cv-00585-RFB-NJK Patent Both District Court, D. Nevada … DISTRICT OF NEVADA 10 11 UNIVERSAL ENTERTAINMENT CORPORATION, …s electronic filing procedures. See Local Rule IA 10-5. Papers filed with the 24 Court under seal must… those 25 documents under seal. See Local Rule IA 10-5(a). 26 The Court has approved the blanket External link to document
2019-04-19 81 Nos. RE46,472 (“the ‘472 Patent”), RE46,473 (“the ‘473 Patent”), 8,088,013 (“the ‘013 Patent”) and 11…11 8,246,047 (“the ‘047 Patent”) (collectively the “UEC Patents” or “Patents-in-Suit”), as well as the… 18 ‘472 and ‘473 Patents 19 • “operation table” (‘472 & ‘473 Patents, all claims) 20 …machine. 21 • “perimeter” (‘472 Patent, claims 1-21; ‘473 Patent, claims 14-29) 22 o Construction… parties acknowledge that the ‘472 Patent 12 and the ‘473 Patent include substantially the same disclosure External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
McKinsey
Dow
Colorcon
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.